Mentions
Extended reach
Total likes
Video views
AI synopsis
Several posts praise the publication for identifying molecular differences in early-onset biliary tract cancers, calling it 'game-changing' and emphasizing the discovery of targetable alterations. The tone, filled with enthusiasm and references to collaborative efforts, indicates a high level of interest and perceived significance, although the overall impact is viewed as promising but still unfolding.
Most discussions highlight support and praise for the research, emphasizing its importance and potential clinical impact, as seen in phrases like 'outstanding work' and 'congratulations.'
The posts demonstrate high curiosity, especially around the implications of molecular differences and targeted therapies for early-onset cases, indicated by words like 'exciting' and 'significant.'
Many comments go beyond surface-level appreciation, mentioning specifics such as genetic markers like FGFR2 fusion, and expressing enthusiasm about future applications and research collaborations.
The discussions reflect a perception that this publication could influence clinical approaches and personalized treatments, though some posts suggest it’s still early to judge the full impact.
Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this work: "Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers." https://t.co/7P33iWslN1 https://t.co/lvJrUtgq2F
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https://t.co/ECsAGfuPa9 @thejusjay @aakonc #gicsm
For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contribution @SKamath_MD @kgnairmd @VaiaFlorou @BiachiTiago @khushmanmd @DrJashDatta @cancerassassin1 @benweinbergmd DrPatGulhati & DrSanjayGoel @RutgersCancer
Outstanding work @tejus_sawjiani ! Early onset cholangio with higher incidence of targetable alterations! Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers | JCO Precision Oncology https://t.co/uGOFDgzaU1
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers | JCO Precision Oncology https://t.co/cwwKhIe5s1 https://t.co/6vKqF1fdag
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
Dr. Alok A Khorana discusses how molecular analysis reveals genetic fusions like FGFR2 and immune marker variations distinguish early-onset biliary tract cancer from typical cases, impacting personalized treatment…
RT @JCOPO_ASCO: Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https…
RT @ThejusJay: For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contrib…
RT @ThejusJay: For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contrib…
RT @ThejusJay: For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contrib…
RT @JCOPO_ASCO: Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https…
RT @JCOPO_ASCO: Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https…
RT @JCOPO_ASCO: Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https…
RT @ThejusJay: For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contrib…
RT @ThejusJay: For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contrib…
For more details- https://t.co/XKwVmCByRI Thanks to experts @ClevelandClinic & across the country for their valuable contribution @SKamath_MD @kgnairmd @VaiaFlorou @BiachiTiago @khushmanmd @DrJashDatta @cancerassassin1 @benweinbergmd DrPatGulhati & DrSanjayGoel @RutgersCancer
RT @JCOPO_ASCO: Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https…
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers | JCO Precision Oncology https://t.co/cwwKhIe5s1 https://t.co/6vKqF1fdag
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers: https://t.co/ECsAGfuPa9 @thejusjay @aakonc #gicsm
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
Outstanding work @tejus_sawjiani ! Early onset cholangio with higher incidence of targetable alterations! Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers | JCO Precision Oncology https://t.co/uGOFDgzaU1
New 3i Investigator Article Alert!! Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers https://t.co/Z46xZPMMZ2
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
RT @cancerassassin1: Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this wo…
Congratulations @ThejusJay @aakonc and multi-institutional collaborative team on publication in @JCOPO_ASCO of this work: "Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers." https://t.co/7P33iWslN1 https://t.co/lvJrUtgq2F